Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
mSphere. 2018 Nov 28;3(6):e00478-18. doi: 10.1128/mSphere.00478-18.
Epigenetic modifications play a pivotal role in the expression of the genes of Epstein-Barr virus (EBV). We found that EBV infection of primary B cells caused moderate induction of enhancer of zeste homolog 2 (EZH2), the major histone H3 lysine 27 (K27) methyltransferase. To investigate the role of EZH2, we knocked out the EZH2 gene in EBV-negative Akata cells by the CRISPR/Cas9 system and infected the cells with EBV, followed by selection of EBV-positive cells. During the latent state, growth of EZH2-knockout (KO) cells was significantly slower after infection compared to wild-type controls, despite similar levels of viral gene expression between cell lines. After induction of the lytic cycle by anti-IgG, KO of EZH2 caused notable induction of expression of both latent and lytic viral genes, as well as increases in both viral DNA replication and progeny production. These results demonstrate that EZH2 is crucial for the intricate epigenetic regulation of not only lytic but also latent gene expression in Akata cells. The life cycle of EBV is regulated by epigenetic modifications, such as CpG methylation and histone modifications. Here, we found that the expression of EZH2, which encodes a histone H3K27 methyltransferase, was induced by EBV infection; therefore, we generated EZH2-KO cells to investigate the role of EZH2 in EBV-infected Akata B cells. Disruption of EZH2 resulted in increased expression of EBV genes during the lytic phase and, therefore, efficient viral replication and progeny production. Our results shed light on the mechanisms underlying reactivation from an epigenetic point of view and further suggest a role for EZH2 as a form of innate immunity that restricts viral replication in infected cells.
表观遗传修饰在 Epstein-Barr 病毒(EBV)基因的表达中起着关键作用。我们发现 EBV 感染原代 B 细胞导致增强子结合蛋白 2(EZH2)的适度诱导,EZH2 是主要的组蛋白 H3 赖氨酸 27(K27)甲基转移酶。为了研究 EZH2 的作用,我们通过 CRISPR/Cas9 系统敲除 EBV 阴性 Akata 细胞中的 EZH2 基因,并用 EBV 感染这些细胞,然后选择 EBV 阳性细胞。在潜伏状态下,与野生型对照相比,EZH2 敲除(KO)细胞在感染后的生长速度明显较慢,尽管两种细胞系之间的病毒基因表达水平相似。在用抗 IgG 诱导裂解周期后,EZH2 的 KO 导致潜伏和裂解病毒基因的表达显著诱导,以及病毒 DNA 复制和后代产生的增加。这些结果表明,EZH2 对于 EBV 在 Akata 细胞中的裂解和潜伏基因表达的复杂表观遗传调控至关重要。EBV 的生命周期受到表观遗传修饰的调节,如 CpG 甲基化和组蛋白修饰。在这里,我们发现编码组蛋白 H3K27 甲基转移酶的 EZH2 的表达被 EBV 感染诱导;因此,我们生成了 EZH2-KO 细胞来研究 EZH2 在 EBV 感染的 Akata B 细胞中的作用。EZH2 的破坏导致裂解期 EBV 基因的表达增加,因此导致有效的病毒复制和后代产生。我们的结果从表观遗传角度揭示了重新激活的机制,并进一步表明 EZH2 作为一种限制感染细胞中病毒复制的先天免疫形式的作用。